Reproductive Factors and Risk of Pancreatic Cancer in Women: A Review of the Literature

Annals of Epidemiology

Volumn 19, Issue 2, 2009, Pages 103-111

  Wahi, Monika M ^a,b   Shah, Nilay ^d   Schrock, Christopher E ^c   Rosemurgy II, Alexander S ^c   Goldin, Steven B ^c  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Pancreatic neoplasms; Reproductive history women; Review literature as topic; Risk factors

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

CANCER RISK; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; COHORT ANALYSIS; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MENARCHE; MENOPAUSE; ORAL CONTRACEPTION; OVARIECTOMY; PANCREAS CANCER; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; WOMEN'S HEALTH;

CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; PANCREATIC NEOPLASMS; PREGNANCY; REPRODUCTIVE HISTORY;

EID: 58749106490     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2008.11.003     Document Type: Review

References (65)

1. Jemal A., Siegel R., Ward E., Hao Y., Murray T., and Thun M.J. Cancer Statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer Statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
3. Lowenfels A.B., Sullivan T., Fiorianti J., and Maisonneuve P. The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep 7 (2005) 90-95
4. Chiu B.C., Lynch C.F., Cerhan J.R., and Cantor K.P. Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa. Ann Epidemiol 11 (2001) 28-37
5. Bonelli L., Aste H., Bovo P., Cavallini G., Felder M., Gusmaroli R., et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in Northern Italy. Pancreas 27 (2003) 143-149
6. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep 51 (2002) 300-303
7. Eberle C.A., Bracci P.M., and Holly E.A. Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area. Cancer Causes Control 16 (2005) 1235-1244
8. Moller H., Mellemgaard A., Lindvig K., and Olsen J.H. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A (1994) 344-350
9. Patel A.V., Rodriguez C., Bernstein L., Chao A., Thun M.J., and Calle E.E. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 14 (2005) 459-466
10. Berrington de Gonzalez A., Sweetland S., and Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89 (2003) 519-523
11. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR). Cancer in Australia 2000 (2003), AIHW, Canberra Rpt No. AIHW Cat. No. CAN 18
12. Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics 2006 (2006), Canada, Toronto Rpt No. ISSN0835-2976
13. Nagenthiraja K., Ewertz M., Engholm G., and Storm H.H. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000. Acta Oncol 46 (2007) 1064-1069
14. Remontet L., Esteve J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51 (2003) 3-30
15. Soliman A.S., Zhang Q., Saleh T., Zarzour A., Selim M., Abdel-Fattah M., et al. Pancreatic cancer mortality in Egypt: comparison to the United States pancreatic cancer mortality rates. Cancer Detect Prev 30 (2006) 473-479
16. Cancer Research UK. UKPancreatic (Pancreas) Cancer Statistics. 2007. Available at: http://info.cancerresearchuk.org/cancerstats/types/pancreas/?a=5441. Accessed May 5, 2008.
17. Qiu D., Kurosawa M., Lin Y., Inaba Y., Matsuba T., Kikuchi S., et al. Overview of the epidemiology of pancreatic cancer focusing on the JACC study. J Epidemiol 15 Suppl. 2 (2005) S157-S167
18. National Cancer Institute. Surveillance Epidemiology and End Results Fast Stats. 2008. Available at: http://seer.cancer.gov/faststats/. Accessed May 5, 2008.
19. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
20. Andren-Sandberg A., Hoem D., and Backman P.L. Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol 10 Suppl. 4 (1999) 131-135
21. Tobacco use among adults-United States, 2005. MMWR Morb Mortal Wkly Rep 55 (2006) 1145-1148
22. Fuchs C.S., Colditz G.A., Stampfer M.J., Giovannucci E.L., Hunter D.J., Rimm E.B., et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156 (1996) 2255-2260
23. Greenway B., Iqbal M.J., Johnson P.J., and Williams R. Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J (Clin Res Ed) 283 (1981) 751-753
24. Sandberg A.A., Kirdani R.Y., Varkarakis M.J., and Murphy G.P. Estrogen receptor protein of pancreas. Steroids 22 (1973) 259-271
25. Sandberg A.A., and Rosenthal H.E. Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem 11 (1979) 293-299
26. Longnecker D.S. Hormones and pancreatic cancer. Int J Pancreatol 9 (1991) 81-86
27. Pomerantz M., Manola J., Taplin M.E., Bubley G., Inman M., Lowell J., et al. Phase I study of low dose and high dose conjugated estrogen for androgen independent prostate cancer. J Urol 177 (2007) 2146-2150
28. Torti F.M. Hormonal therapy for prostate cancer. N Engl J Med 311 (1984) 1313-1314
29. Waxman J. Hormonal aspects of prostatic cancer: a review. J R Soc Med 78 (1985) 129-135
30. Martin M.B., and Stoica A. Insulin-like growth factor-I and estrogen interactions in breast cancer. J Nutr 132 (2002) 3799S-3801S
31. Slattery M.L., Ballard-Barbash R., Edwards S., Caan B.J., and Potter J.D. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 14 (2003) 75-84
32. Ohmura E., Okada M., Onoda N., Kamiya Y., Murakami H., Tsushima T., et al. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 50 (1990) 103-107
33. Bergmann U., Funatomi H., Yokoyama M., Beger H.G., and Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55 (1995) 2007-2011
34. Krattenmacher R., Knauthe R., Parczyk K., Walker A., Hilgenfeldt U., and Fritzemeier K.H. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem Mol Biol 48 (1994) 207-214
35. Holmes M.D., Pollak M.N., and Hankinson S.E. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11 (2002) 862-867
36. Paassilta M., Karjalainen A., Kervinen K., Savolainen M.J., Heikkinen J., Backstrom A.C., et al. Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels. Atherosclerosis 149 (2000) 157-162
37. Cano A., Castelo-Branco C., and Tarin J.J. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil Steril 71 (1999) 261-267
38. Benz C., Hollander C., and Miller B. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res. 46 (1986) 2276-2281
39. Keating J.J., Johnson P.J., Cochrane A.M., Gazzard B.G., Krasner N., Smith P.M., et al. A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. Br J Cancer 60 (1989) 789-792
40. Bueno de Mesquita H.B., Maisonneuve P., Moerman C.J., and Walker A.M. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in the Netherlands. Int J Cancer 52 (1992) 24-29
41. Cantor K.P., Lynch C.F., and Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 4 (1993) 505-511
42. Duell E.J., and Holly E.A. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol 161 (2005) 741-747
43. Fernandez E., La Vecchia C., D'Avanzo B., and Negri E. Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer 62 (1995) 11-14
44. Hanley A.J., Johnson K.C., Villeneuve P.J., and Mao Y. Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian Enhanced Cancer Surveillance System. Int J Cancer 94 (2001) 140-147
45. Ji B.T., Hatch M.C., Chow W.H., McLaughlin J.K., Dai Q., Howe G.R., et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 66 (1996) 432-437
46. Kalapothaki V., Tzonou A., Hsieh C.C., Toupadaki N., Karakatsani A., and Trichopoulos D. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 4 (1993) 375-382
47. Karlson B.M., Wuu J., Hsieh C.C., Lambe M., and Ekbom A. Parity and the risk of pancreatic cancer: a nested case-control study. Int J Cancer 77 (1998) 224-227
48. Kreiger N., Lacroix J., and Sloan M. Hormonal factors and pancreatic cancer in women. Ann Epidemiol 11 (2001) 563-567
49. Lo A.C., Soliman A.S., El-Ghawalby N., Abdel-Wahab M., Fathy O., Khaled H.M., et al. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 35 (2007) 120-129
50. Lin Y., Kikuchi S., Tamakoshi A., Kawamura T., Inaba Y., Kurosawa M., et al. Association of menstrual and reproductive factors with pancreatic cancer risk in women: Findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Gastroenterol 41 (2006) 878-883
51. Navarro Silvera S.A., Miller A.B., and Rohan T.E. Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas 30 (2005) 369-374
52. Prizment A.E., Anderson K.E., Hong C.P., and Folsom A.R. Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study. JOP 8 (2007) 16-27
53. Skinner H.G., Michaud D.S., Colditz G.A., Giovannucci E.L., Stampfer M.J., Willett W.C., et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 12 (2003) 433-438
54. Teras L.R., Patel A.V., Rodriguez C., Thun M.J., and Calle E.E. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control 16 (2005) 1035-1040
55. Casey P.M., Cerhan J.R., and Pruthi S. Oral contraceptive use and risk of breast cancer. Mayo Clin Proc 83 (2008) 86-90 quiz 90-91
56. Chambers J. R Software version 2.6.1. Vienna, Austria: The R foundation for Statistical Computing; 2008.
57. Liu J.M., Hankinson S.E., Stampfer M.J., Rifai N., Willett W.C., and Ma J. Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr 78 (2003) 1160-1167
58. Milman N., Byg K.E., and Ovesen L. Iron status in Danes 1994. II: Prevalence of iron deficiency and iron overload in 1319 Danish women aged 40-70 years. Influence of blood donation, alcohol intake and iron supplementation. Ann Hematol 79 (2000) 612-621
59. Weinberg E.D. The role of iron in cancer. Eur J Cancer Prev 5 (1996) 19-36
60. Friedman G.D., and van den Eeden S.K. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 22 (1993) 30-37
61. Silverman D.T., Swanson C.A., Gridley G., Wacholder S., Greenberg R.S., Brown L.M., et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 90 (1998) 1710-1719
62. Brett K.M. Can hysterectomy be considered a risk factor for cardiovascular disease?. Circulation 111 (2005) 1456-1458
63. Prentice RL. The population science research agenda and the Women's Health Initiative presented at Joint Statistical Meeting 2008, Denver, CO, August 6, 2008.
64. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
65. Kapoor D., and Jones T.H. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152 (2005) 491-499